Assembly Biosciences Inc
F:V7B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Assembly Biosciences Inc
F:V7B
|
US |
|
P
|
Procter & Gamble Co
F:PRG
|
US |
|
G
|
Gap Inc
XBER:GAP
|
US |
|
Schibsted ASA
F:XPG
|
NO |
Shareholder Yield
Current shareholder yield for 
V7B is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
V7B Price
Assembly Biosciences Inc
| Average Annual Return | -11.82% |
| Standard Deviation of Annual Returns | 53.31% |
| Max Drawdown | -82% |
| Market Capitalization | 726.5m EUR |
| Shares Outstanding | 15 820 000 |
| Percentage of Shares Shorted |
N/A
|
V7B Return Decomposition
Main factors of price return
Stock Splits
V7B's latest stock split occurred on Feb 12, 2024
The company executed a 1-for-12 stock split, meaning that for every 12 shares held, investors received 1 new share.
Before the split, V7B traded at 0.947 per share. Afterward, the share price was about 11.364.
The adjusted shares began trading on Feb 12, 2024. This was stock split number 2 in V7B's history, following the previous one in Jul 14, 2014.
